Pentagrit CRO leverages the zebrafish model for comprehensive pharmacokinetic (PK) analysis, providing a robust platform for evaluating drug absorption, distribution, metabolism, and excretion (ADME). Zebrafish offer a unique combination of rapid development, genetic similarity to humans, and transparency, allowing for real-time imaging and detailed pharmacokinetic profiling. With a dedicated focus on high-throughput screening and advanced analytical methods, Pentagrit delivers reliable PK data essential for preclinical drug development.